Diabetic nephropathy: landmark clinical trials and tribulations.
about
Recent advances in managing and understanding diabetic nephropathyRenal Biopsy in Type 2 Diabetic PatientsAnti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities.Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'-implications for pre-clinical research and drug testing.Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy.Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle.Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.Protective effect of L-glutamine against diabetes-induced nephropathy in experimental animal: Role of KIM-1, NGAL, TGF-β1, and collagen-1.Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase.Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.Early and late scanning electron microscopy findings in diabetic kidney disease.Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.
P2860
Q26745900-93FD1F4F-B415-4AB4-B943-164FDD4E6183Q26799509-ED79AE54-9C92-441E-9FCD-F6B3F248DEC3Q35895011-1DFEB882-7249-4BF1-BAB5-8B6403C48482Q36948557-565E4F39-C76B-4B07-A60B-BB23DD181678Q37178054-0CAB9458-523F-4918-A20D-0265BE505FB6Q37735321-6CF3C3C7-65AE-4554-9507-0775985DBE76Q38627117-5E42E824-A24E-4635-931A-F1A43A827952Q38885386-4E512738-410D-47E2-AA97-F7F386B6E65EQ41181786-318BE557-2D07-47F4-91F3-96591F39A4D9Q41989543-E0C2C28A-FE3B-4D6E-90AD-10BA5FAA5961Q42368625-C45A95D4-D40B-4F3B-9562-5B0E83C2800CQ47108521-C8E0EDC9-D1D9-4D91-A39D-A286D34F064DQ47131660-AA5E5766-DBD4-49D1-A05E-A903B3961583Q47252604-D77C18CD-B2C2-49BF-804B-AB4939C1B6D6Q51378901-C0C5CF9D-45F0-4AD8-AF11-7B464AE4CC74Q53295837-6F636638-93F9-4C86-9C05-15EEBF2DDCAEQ53296448-6132A936-A624-431E-AB46-4A5C20788DDBQ54998190-F7E84B5F-372A-4D21-8263-03C69BDA3D7BQ55454896-EC29AF7E-E717-4B01-9F0F-A0DB10A66F73
P2860
Diabetic nephropathy: landmark clinical trials and tribulations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Diabetic nephropathy: landmark clinical trials and tribulations.
@en
type
label
Diabetic nephropathy: landmark clinical trials and tribulations.
@en
prefLabel
Diabetic nephropathy: landmark clinical trials and tribulations.
@en
P2860
P356
P1476
Diabetic nephropathy: landmark clinical trials and tribulations.
@en
P2093
Gary C W Chan
P2860
P304
P356
10.1093/NDT/GFU411
P407
P577
2015-01-29T00:00:00Z